{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:55:06Z","timestamp":1761630906717},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:00:00Z","timestamp":1587513600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:00:00Z","timestamp":1587513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Progressive familial intrahepatic cholestasis (PFIC) is a rare group of autosomal recessive hereditary hepatic diseases. There are three types of PFIC, classified according to the mutated gene. For example, PFIC type 3 (PFIC3) is due to mutations in the <jats:italic>ABCB4<\/jats:italic> gene (encoding multidrug-resistant protein 3 [MDR3]).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>We present a 19-year-old Chinese female patient who had a 2-year history of recurrent liver dysfunction, with mainly elevated alkaline phosphatase and \u03b3-glutamyl transpeptidase(\u03b3-GT) levels. After excluding other causes of abnormal liver function and cholestasis, the final diagnosis of PFIC3 was confirmed by histopathological examination and gene detection. The immunohistochemical results showed no MDR3 protein expression in the bile duct membrane. Genetic sequencing analysis revealed a novel heterozygous 2137G\u2009&gt;\u2009A; p. V713M mutation (Exon 17) and a synonymous 504C\u2009&gt;\u2009T; p. N168N mutation (Exon 6) in <jats:italic>ABCB4<\/jats:italic>.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Our patient with long-term liver dysfunction demonstrated that elevated alkaline phosphatase and \u03b3-GT levels should be associated with the diagnosis of PFIC3, and gene detection is the key to diagnosis. From our in silico analysis, the novel mutation p. V713M in Exon 17 was predicted to affect protein function, with a SIFT (Sorting Intolerant from Tolerant) score of 0.02, indicating a deleterious effect. Further studies are necessary to investigate the impact of the novel heterozygous 2137G\u2009&gt;\u2009A; p. V713M mutation (Exon 17) on functional defects of MDR3 and PFIC3.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13000-020-00955-7","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T06:02:46Z","timestamp":1587535366000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Novel ABCB4 mutation in a Chinese female patient with progressive familial intrahepatic cholestasis type 3: a case report"],"prefix":"10.1186","volume":"15","author":[{"given":"Zhenping","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lunli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,22]]},"reference":[{"issue":"4","key":"955_CR1","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cld.2018.06.003","volume":"22","author":"LN Bull","year":"2018","unstructured":"Bull LN, Thompson RJ. Progressive familial intrahepatic cholestasis. Clin Liver Dis. 2018;22(4):657\u201369.","journal-title":"Clin Liver Dis"},{"issue":"3","key":"955_CR2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.jhep.2016.04.032","volume":"65","author":"HJ Verkade","year":"2016","unstructured":"Verkade HJ, Bezerra JA, Davenport M, Schreiber RA, Mieli-Vergani G, Hulscher JB, et al. Biliary atresia and other cholestatic childhood diseases: advances and future challenges. J Hepatol. 2016;65(3):631\u201342.","journal-title":"J Hepatol"},{"issue":"1","key":"955_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jceh.2013.10.005","volume":"4","author":"A Srivastava","year":"2014","unstructured":"Srivastava A. Progressive familial intrahepatic cholestasis. J Clin Exp Hepatol. 2014;4(1):25\u201336.","journal-title":"J Clin Exp Hepatol"},{"issue":"6","key":"955_CR4","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1053\/gast.2001.23984","volume":"120","author":"E Jacquemin","year":"2001","unstructured":"Jacquemin E, De Vree JM, Cresteil D, Sokal EM, Sturm E, Dumont M, et al. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology. 2001;120(6):1448\u201358.","journal-title":"Gastroenterology."},{"issue":"4","key":"955_CR5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/MCG.0000000000000474","volume":"50","author":"Z Wang","year":"2016","unstructured":"Wang Z, Yang F, Wang J, Ma X. A novel mutation of ABCB4 in progressive familial intrahepatic cholestasis 3: like mother, Like Daughter. J Clin Gastroenterol. 2016;50(4):353\u20134.","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"955_CR6","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3748\/wjg.v21.i2.699","volume":"21","author":"HZ Sun","year":"2015","unstructured":"Sun HZ, Shi H, Zhang SC, Shen XZ. Novel mutation in a Chinese patient with progressive familial intrahepatic cholestasis type 3. World J Gastroenterol. 2015;21(2):699\u2013703.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"955_CR7","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/MPG.0b013e31824ef36f","volume":"55","author":"LJ Fang","year":"2012","unstructured":"Fang LJ, Wang XH, Knisely AS, Yu H, Lu Y, Liu LY, et al. Chinese children with chronic intrahepatic cholestasis and high gamma-glutamyl transpeptidase: clinical features and association with ABCB4 mutations. J Pediatr Gastroenterol Nutr. 2012;55(2):150\u20136.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"10","key":"955_CR8","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1172\/JCI119799","volume":"100","author":"AR Crawford","year":"1997","unstructured":"Crawford AR, Smith AJ, Hatch VC, Oude Elferink RP, Borst P, Crawford JM. Hepatic secretion of phospholipid vesicles in the mouse critically depends on mdr2 or MDR3 P-glycoprotein expression. Visualization by electron microscopy. J Clin Invest. 1997;100(10):2562\u20137.","journal-title":"J Clin Invest"},{"issue":"5","key":"955_CR9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00424-006-0062-9","volume":"453","author":"RP Oude Elferink","year":"2007","unstructured":"Oude Elferink RP, Paulusma CC. Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein). Pflugers Arch. 2007;453(5):601\u201310.","journal-title":"Pflugers Arch"},{"issue":"Suppl 1","key":"955_CR10","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/S2210-7401(12)70018-9","volume":"36","author":"E Jacquemin","year":"2012","unstructured":"Jacquemin E. Progressive familial intrahepatic cholestasis. Clin Res Hepatol Gastroenterol. 2012;36(Suppl 1):S26\u201335.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"955_CR11","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.cell.2014.01.051","volume":"156","author":"F Supek","year":"2014","unstructured":"Supek F, Minana B, Valcarcel J, Gabaldon T, Lehner B. Synonymous mutations frequently act as driver mutations in human cancers. Cell. 2014;156:1324\u201335.","journal-title":"Cell."},{"key":"955_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/1471-230X-14-160","volume":"14","author":"K Kamimura","year":"2014","unstructured":"Kamimura K, Abe H, Kamimura N, Yamaguchi M, Mamizu M, Ogi K, et al. Successful management of severe intrahepatic cholestasis of pregnancy: report of a first Japanese case. BMC Gastroenterol. 2014;14:160.","journal-title":"BMC Gastroenterol"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-020-00955-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-020-00955-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-020-00955-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T23:54:52Z","timestamp":1619049292000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-020-00955-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,22]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["955"],"URL":"https:\/\/doi.org\/10.1186\/s13000-020-00955-7","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,22]]},"assertion":[{"value":"17 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethics committee of The first affiliated hospital of Nanchang University, Nanchang China (No. 201920). Written informed consent was obtained from the patient for the storage of samples and data, follow-up contact, and further use of samples and data for research purposes.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}